BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 17040201)

  • 1. Novel therapies for rheumatoid arthritis.
    Tremoulet AH; Albani S
    Expert Opin Investig Drugs; 2006 Nov; 15(11):1427-41. PubMed ID: 17040201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging drugs for rheumatoid arthritis.
    Voulgari PV
    Expert Opin Emerg Drugs; 2008 Mar; 13(1):175-96. PubMed ID: 18321156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological therapies for rheumatoid arthritis: progress to date.
    Malviya G; Salemi S; Laganà B; Diamanti AP; D'Amelio R; Signore A
    BioDrugs; 2013 Aug; 27(4):329-45. PubMed ID: 23558378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy.
    Alam J; Jantan I; Bukhari SNA
    Biomed Pharmacother; 2017 Aug; 92():615-633. PubMed ID: 28582758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigational agents for rheumatoid arthritis.
    Merkel PA; Letourneau EN; Polisson RP
    Rheum Dis Clin North Am; 1995 Aug; 21(3):779-96. PubMed ID: 8619099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases.
    Siebert S; Tsoukas A; Robertson J; McInnes I
    Pharmacol Rev; 2015; 67(2):280-309. PubMed ID: 25697599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abatacept: a novel treatment for rheumatoid arthritis.
    Lundquist LM
    Expert Opin Pharmacother; 2007 Oct; 8(14):2371-9. PubMed ID: 17927490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of rheumatoid arthritis.
    Gaffo A; Saag KG; Curtis JR
    Am J Health Syst Pharm; 2006 Dec; 63(24):2451-65. PubMed ID: 17158693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New therapeutics in rheumatoid arthritis.
    Savage C; St Clair EW
    Rheum Dis Clin North Am; 2006 Feb; 32(1):57-74, viii. PubMed ID: 16504821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis.
    Azizi G; Jadidi-Niaragh F; Mirshafiey A
    Int J Rheum Dis; 2013 Jun; 16(3):243-53. PubMed ID: 23981743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological agents in rheumatoid arthritis.
    Shankar S; Handa R
    J Postgrad Med; 2004; 50(4):293-9. PubMed ID: 15623977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Conventional and Biological Disease Modifying Antirheumatic Drugs on Bone Biology. Rheumatoid Arthritis as a Case Study.
    Barreira SC; Fonseca JE
    Clin Rev Allergy Immunol; 2016 Aug; 51(1):100-9. PubMed ID: 27166684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic options for rheumatoid arthritis.
    Feely MG; Erickson A; O'Dell JR
    Expert Opin Pharmacother; 2009 Sep; 10(13):2095-106. PubMed ID: 19606939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological therapies for rheumatoid arthritis.
    Edwards CJ
    Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathogenic Mechanisms and Novel Immune-Modulated Therapies in Rheumatoid Arthritis.
    Chen SJ; Lin GJ; Chen JW; Wang KC; Tien CH; Hu CF; Chang CN; Hsu WF; Fan HC; Sytwu HK
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging therapeutics for rheumatoid arthritis.
    Bingham CO
    Bull NYU Hosp Jt Dis; 2008; 66(3):210-5. PubMed ID: 18937634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatoid arthritis: an overview of new and emerging therapies.
    Doan T; Massarotti E
    J Clin Pharmacol; 2005 Jul; 45(7):751-62. PubMed ID: 15951465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacological properties and clinical efficacy of abatacept (Orencia(®)) for the treatment of rheumatoid arthritis].
    Yasuoka Y; Goto A; Seriu T
    Nihon Yakurigaku Zasshi; 2011 Feb; 137(2):87-94. PubMed ID: 21321458
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumour necrosis factor α antagonists in the treatment of rheumatoid arthritis: an immunological perspective.
    Meroni PL; Valesini G
    BioDrugs; 2014 Apr; 28 Suppl 1():S5-13. PubMed ID: 24687234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting IL-6 for the treatment of rheumatoid arthritis: Phase II investigational drugs.
    Semerano L; Thiolat A; Minichiello E; Clavel G; Bessis N; Boissier MC
    Expert Opin Investig Drugs; 2014 Jul; 23(7):979-99. PubMed ID: 24766460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.